NYSE · Biotech stocks database
CRL — Charles River Laboratories International Inc.
CRL (Charles River Laboratories International Inc.) stock: $278.61, $13.30B market cap, $192.0M cash, $13.11B EV, $13.49B fully diluted market cap. Data from Fully Diluted's biotech stocks database.
Enterprise value
$13,108.5M
Balance sheet
| Cash | $192.0M |
|---|
| Debt | $0.0M |
|---|
| Net cash | $192.0M |
|---|
| Enterprise value | $13,108.5M |
|---|
| Basic shares | 47.7M shares |
|---|
| Fully diluted shares | 48.4M shares |
|---|
| Fully diluted market cap | $13,492.8M |
|---|
| Cash per share | $4.03 |
|---|
Cash figures as of 2026-06-27. Database snapshot: 2026-09-22.
Price history
Loading CRL daily closes…
Loading price history…
Asset data not yet available for this company.
No lead program on file for this company.
No active ClinicalTrials.gov trials matched to this company as sponsor or collaborator.
No specialist-fund holders in 13F data for this company.